Wellington Management Group LLP Y M Abs Therapeutics, Inc. Transaction History

Wellington Management Group LLP

  • $503 Billion
  • Q1 2025

A detailed history of Wellington Management Group LLP transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 204,052 shares of YMAB stock, worth $861,099. This represents 0.0% of its overall portfolio holdings.

Number of Shares
204,052
Holding current value
$861,099
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$4.43 - $8.17 $903,950 - $1.67 Million
204,052 New
204,052 $903,000
Q4 2024

Feb 12, 2025
SELL
$7.76 - $15.69 $26,779 - $54,146
-3,451 Reduced 2.52%
133,263 $1.04 Million
Q3 2024

Nov 14, 2024
SELL
$9.95 - $15.39 $236,113 - $365,204
-23,730 Reduced 14.79%
136,714 $1.8 Million
Q2 2024

Aug 13, 2024
BUY
$11.6 - $17.25 $164,035 - $243,932
14,141 Added 9.67%
160,444 $1.94 Million
Q1 2024

May 15, 2024
BUY
$6.57 - $18.69 $961,210 - $2.73 Million
146,303 New
146,303 $2.38 Million
Q3 2022

Nov 14, 2022
BUY
$13.96 - $19.67 $1.09 Million - $1.54 Million
78,090 Added 4.18%
1,948,469 $28.1 Million
Q2 2022

Aug 15, 2022
SELL
$8.22 - $15.13 $330,435 - $608,210
-40,199 Reduced 2.1%
1,870,379 $28.3 Million
Q1 2022

May 16, 2022
SELL
$6.55 - $17.42 $15.5 Million - $41.1 Million
-2,360,804 Reduced 55.27%
1,910,578 $22.7 Million
Q4 2021

Feb 11, 2022
SELL
$15.51 - $29.31 $104,149 - $196,816
-6,715 Reduced 0.16%
4,271,382 $69.2 Million
Q3 2021

Nov 15, 2021
SELL
$27.47 - $37.31 $4.68 Million - $6.36 Million
-170,513 Reduced 3.83%
4,278,097 $122 Million
Q2 2021

Aug 16, 2021
BUY
$25.45 - $37.64 $36.3 Million - $53.8 Million
1,428,152 Added 47.28%
4,448,610 $150 Million
Q1 2021

May 17, 2021
BUY
$29.16 - $51.96 $16.9 Million - $30.2 Million
580,649 Added 23.8%
3,020,458 $91.3 Million
Q4 2020

Feb 12, 2021
SELL
$37.86 - $54.26 $8.15 Million - $11.7 Million
-215,243 Reduced 8.11%
2,439,809 $121 Million
Q3 2020

Nov 16, 2020
BUY
$35.13 - $43.62 $11.5 Million - $14.3 Million
327,126 Added 14.05%
2,655,052 $102 Million
Q2 2020

Aug 14, 2020
SELL
$23.66 - $49.53 $9.85 Million - $20.6 Million
-416,379 Reduced 15.17%
2,327,926 $101 Million
Q1 2020

May 14, 2020
BUY
$14.39 - $35.8 $4.14 Million - $10.3 Million
287,679 Added 11.71%
2,744,305 $71.6 Million
Q4 2019

Feb 11, 2020
BUY
$23.81 - $33.78 $58.5 Million - $83 Million
2,456,626 New
2,456,626 $76.8 Million

Others Institutions Holding YMAB

# of Institutions
103
Shares Held
27.1M
Call Options Held
38.4K
Put Options Held
2.1K
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $184M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email